Superworth

Large drugmakers with the highest profit margins

Net income over the last twelve months as a share of revenue. As of .

Ranked
85
of 411 large drugmakers we cover
Median
−5.1%
Highest
97.7%
AUPH
Range
−97.0% to 97.7%
median −5.1%
−96.9%84.2%
#CompanyNet marginOperating marginRevenue growth (TTM)Market cap
1AUPHAurinia Pharmaceuticals97.7%48.6%+21.0%$2.2B
2ABUSArbutus Biopharma84.2%82.0%n/m$791.4M
3INVAInnoviva81.2%36.9%+18.8%$1.5B
4LGNDLigand Pharmaceuticals67.9%32.6%+54.9%$6.1B
5TGTXTG Therapeutics55.2%17.1%+76.1%$9.2B
6ZVRAZevra Therapeutics42.8%60.5%+119.4%$599.8M
7NRIXNurix Therapeutics42.0%41.3%n/m$2.8B
8CRMDCorMedix40.5%47.0%+280.5%$420.1M
9ACADAcadia Pharmaceuticals33.4%7.6%+11.8%$3.5B
10IRWDIronwood Pharmaceuticals33.4%60.1%+26.2%$571.7M
11INDVIndivior Pharmaceuticals32.8%40.6%+16.3%$4.3B
12LLYEli Lilly and31.9%40.3%+45.5%$1.3T
13LQDALiquidia30.7%37.4%n/m$3.7B
14PTGXProtagonist Therapeutics29.4%20.7%+34.8%$9B
15AMGNAmgen23.0%30.0%+9.1%$252.3B
16JAZZJazz Pharmaceuticals20.4%19.5%+12.6%$13.9B
17HRMYHarmony Biosciences18.9%24.0%+24.3%$2.2B
18BMYBristol-Myers Squibb18.5%n/m+4.2%$128.7B
19ABBVAbbVie15.7%32.2%+10.7%$511.6B
20PBHPrestige Consumer Healthcare15.6%26.3%−1.4%$2.4B
21PBYIPuma Biotechnology11.6%13.2%−2.9%$525.5M
22ANIPANI Pharmaceuticals11.1%15.4%+30.9%$1.6B
23AMPHAmphastar Pharmaceuticals10.8%15.7%+1.0%$1.1B
24KNSAKiniksa Pharmaceuticals International9.6%11.9%+58.9%$7.1B
25BIIBBiogen8.3%12.3%+0.3%$37B
26PFEPfizer6.8%21.7%−0.2%$176B
27CORTCorcept Therapeutics6.6%0.8%+16.0%$8.7B
28PAHCPhibro Animal Health6.6%12.8%+17.1%$1.6B
29ARQTArcutis Biotherapeutics6.1%7.4%+76.1%$3.9B
30COLLCollegium Pharmaceutical5.9%19.5%+14.3%$770.9M
31AMRXAmneal Pharmaceuticals5.0%14.6%+9.3%$6.5B
32ALKSAlkermes plc.4.0%7.0%+10.8%$7.5B
33NATRNatures Sunshine Products3.7%6.0%+6.8%$211.5M
34MRKMerck3.6%n/m+4.9%$359.5B
35OGNOrganon3.5%13.6%−3.2%$3.6B
36ARVNArvinas2.9%−5.7%−15.0%$491.7M
37LFVNLifevantage2.8%3.3%−20.1%$73.5M
38BMRNBiomarin Pharmaceutical2.1%4.4%+11.2%$11.1B
39PCRXPacira BioSciences2.0%2.7%+5.7%$1.5B
40ASMBAssembly Biosciences−0.1%−11.8%+125.1%$397.2M
41ELANElanco Animal Health−4.0%1.6%+12.0%$12B
42SUPNSupernus Pharmaceuticals−5.1%−5.7%+26.9%$2.1B
43XERSXeris Biopharma−5.1%10.9%+36.3%$1.9B
44SIGASiga Technologies−5.2%−20.8%−70.1%$212M
45SRPTSarepta Therapeutics−6.9%n/m−20.4%$1.9B
46RMTIRockwell Medical−7.3%−6.5%−21.1%$27.9M
47TVTXTravere Therapeutics−7.4%−6.8%+49.4%$4.6B
48BHCBausch Health Companies−7.6%11.2%+10.8%$3B
49MGNXMacrogenics−8.7%−24.3%+11.7%$148.4M
50DERMJourney Medical−9.0%−4.4%+20.9%$135.2M
51PTCTPTC Therapeutics−9.2%12.8%−35.1%$5.1B
52EOLSEvolus−10.8%−5.9%+13.9%$472.9M
53MNKDMannkind−11.1%2.3%+30.5%$1.2B
54ARDXArdelyx−12.4%−7.9%+16.8%$755M
55OPKOpko Health−12.4%−8.2%−11.5%$1.3B
56GILDGilead Sciences−12.5%−7.6%+6.5%$212.5B
57HROWHarrow−13.5%−1.0%+21.1%$1.1B
58AKBAAkebia Therapeutics−13.5%−6.9%+7.5%$196.3M
59AMRNAmarin Corp Plc−14.6%−21.9%−15.1%$256.2M
60GYREGyre Therapeutics−15.5%−14.0%+13.5%$527.4M
61ORGOOrganogenesis−18.4%−7.8%+6.5%$97.2M
62CYRXCryoport−20.1%−21.2%+12.1%$822M
63SDGRSchrodinger−21.0%−59.2%+8.9%$2B
64HRTXHeron Therapeutics−22.5%−7.2%+1.0%$56M
65EBSEmergent BioSolutions−23.0%−8.6%−17.7%$330.2M
66SEPNSepterna−24.5%−44.0%n/m$2B
67AXSMAxsome Therapeutics−24.7%−24.0%+56.9%$7.1B
68AYTUAytu Biopharma−24.8%−14.4%−13.3%$21.1M
69MDGLMadrigal Pharmaceuticals−25.3%−25.1%+149.0%$10B
70PHATPhathom Pharmaceuticals−30.2%−9.3%+86.8%$480.8M
71GERNGeron−33.1%−25.3%+24.4%$596.9M
72MRVIMaravai Lifesciences−37.1%−56.1%−5.0%$1.9B
73PRGOPERRIGO−41.9%−37.7%−4.2%$2.2B
74ZLABZai Lab−41.9%−58.7%+5.1%$2.4B
75ARWRArrowhead Pharmaceuticals−47.8%−33.8%+16.8%$8.4B
76URGNUroGen Pharma−51.7%−35.3%+100.3%$1.7B
77IONSIonis Pharmaceuticals−64.7%−68.0%−7.4%$6.9B
78IDYAIDEAYA Biosciences−74.8%−92.7%n/m$3.1B
79PRTAProthena Corp Public−80.7%n/mn/m$425.6M
80RAREUltragenyx Pharmaceutical−81.7%−73.6%+17.4%$1.6B
81RYTMRhythm Pharmaceuticals−85.6%−83.6%+53.5%$6.4B
82SNDXSyndax Pharmaceuticals−87.5%−77.0%+159.7%$1.2B
83NUVBNuvation Bio−88.2%−81.0%n/m$1.6B
84ENTAEnanta Pharmaceuticals−96.9%−90.0%+0.7%$303.8M
85BBIOBridgeBio Pharma−97.0%−69.8%+202.4%$14.7B

Not ranked: 91 with not a meaningful number, 75 with a margin moved by items that are not sales, 62 with a quarter missing, 11 with no margin to measure, 9 with under $50M of revenue. 78 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

Net margin for other groups

Other rankings of large drugmakers

The group